What is the share price of Remus Pharmaceuticals Ltd (REMUS) today?
The share price of REMUS as on 11th March 2025 is ₹1977.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Remus Pharmaceuticals Ltd (REMUS) share?
The past returns of Remus Pharmaceuticals Ltd (REMUS) share are- Past 1 week: -3.54%
- Past 1 month: -3.33%
- Past 3 months: -21.25%
- Past 6 months: -21.18%
- Past 1 year: 38.83%
- Past 3 years: N/A%
- Past 5 years: 340.32%
What are the peers or stocks similar to Remus Pharmaceuticals Ltd (REMUS)?
The peers or stocks similar to Remus Pharmaceuticals Ltd (REMUS) include:What is the market cap of Remus Pharmaceuticals Ltd (REMUS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd (REMUS) is ₹1141.46 Cr as of 11th March 2025.What is the 52 week high and low of Remus Pharmaceuticals Ltd (REMUS) share?
The 52-week high of Remus Pharmaceuticals Ltd (REMUS) is ₹2834.75 and the 52-week low is ₹1200.What is the PE and PB ratio of Remus Pharmaceuticals Ltd (REMUS) stock?
The P/E (price-to-earnings) ratio of Remus Pharmaceuticals Ltd (REMUS) is 52.99. The P/B (price-to-book) ratio is 10.94.Which sector does Remus Pharmaceuticals Ltd (REMUS) belong to?
Remus Pharmaceuticals Ltd (REMUS) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Remus Pharmaceuticals Ltd (REMUS) shares?
You can directly buy Remus Pharmaceuticals Ltd (REMUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Remus Pharmaceuticals Ltd
REMUSRemus Pharmaceuticals Ltd
REMUS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,141 cr, stock is ranked 1,309
High RiskStock is 4.52x as volatile as Nifty
1,977.902.10% (+40.60)
1,977.902.10% (+40.60)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 10.94 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.89 | 5.97 | 0.56% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Remus Pharmaceuticals Ltd markets and distributes pharmaceutical formulations and active pharmaceutical ingredients, specializing in various therapeutic areas including oncology and cardiovascular health.
Peers
Compare with peersSUNPHARMA
PE Ratio
40.38
1Y Return
1.12%
Buy Reco %
85.29
CIPLA
PE Ratio
28.66
1Y Return
2.75%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.75
1Y Return
13.84%
Buy Reco %
68.00
DRREDDY
PE Ratio
16.73
1Y Return
12.31%
Buy Reco %
45.16
MANKIND
PE Ratio
48.73
1Y Return
4.48%
Buy Reco %
80.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2024 | TTM | ||
|---|---|---|---|---|
| Total Revenue | 217.90 | — | ||
Raw Materials | 164.99 | — | ||
| Power & Fuel Cost | 0.00 | |||
| Employee Cost | 7.42 | |||
| Selling & Administrative Expenses | 5.25 | |||
| Operating & Other expenses | 7.02 | |||
EBITDA | 33.22 | — | ||
| Depreciation/Amortization | 0.90 | — | ||
| PBIT | 32.32 | — | ||
| Interest & Other Items | 0.48 | — | ||
| PBT | 31.84 | — | ||
| Taxes & Other Items | 10.30 | — | ||
| Net Income | 21.54 | — | ||
| EPS | 36.56 | — | ||
| DPS | 0.00 | — | ||
| Payout ratio | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Remus Pharmaceuticals Ltd | 52.99 | 10.94 | — |
| Sun Pharmaceutical Industries Ltd | 40.38 | 5.76 | 0.84% |
| Cipla Ltd | 28.66 | 4.41 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.75 | 15.16 | 0.91% |
Price Comparison
Compare REMUS with any stock or ETFCompare REMUS with any stock or ETF
REMUS
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
REMUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 19, 2024
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 19, 2024
Cash Dividend
Ex DateEx DateMay 2, 2024
Interim 2
Interim 2 | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
May 2, 2024
Cash Dividend
Ex DateEx DateOct 27, 2023
Interim
Interim | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Oct 27, 2023
Cash Dividend
Ex DateEx DateSep 15, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 15, 2023
News & Opinions
Articles & Videos
Corporate
Board of Remus Pharmaceuticals recommends interim dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 November 2024, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene board meeting
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene AGM
Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant